You are viewing: Rest Of Europe AI in Precision Medicine Market analysis

The Rest Of Europe AI in Precision Medicine Market was valued at $41.99 Million in 2024 and projected to reach to $212.47 Million by 2029, representing a compound annual growth rate of 31.0%. Rest Of Europe's AI in Precision Medicine market is positioned for exceptional growth through 2029, driven by increasing healthcare expenditure, regulatory support for digital health solutions, and rising demand for personalized treatment approaches.

Rest Of Europe AI in Precision Medicine Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe AI in Precision Medicine Market Trends and Insights

  • This represents a compound annual growth rate of 31.0%, reflecting strong adoption of AI-driven diagnostic and treatment solutions across the region.
  • Rest Of Europe is capitalizing on advances in machine learning, genomic sequencing, and real-world data analytics to enhance clinical decision-making and patient outcomes. The growth trajectory in Rest Of Europe is driven by increasing healthcare digitalization, rising prevalence of chronic diseases, and regulatory support for precision medicine initiatives.
  • Rest Of Europe's healthcare systems are investing heavily in AI infrastructure and talent to compete with leading European markets.
  • By 2029, Rest Of Europe is expected to establish itself as a significant hub for AI-enabled precision medicine applications, supported by collaborative research networks and public-private partnerships across the region..

Key Market Statistics

  • CAGR (2024-2029) 31.0% CAGR
  • Market Size, 2024 ~USD 41.99 Million
  • Forecast, 2029 ~USD 212.47 Million
  • Country Rest Of Europe

Rest Of Europe AI in Precision Medicine Market Overview

Rapid Market Expansion :

Rest Of Europe's AI in Precision Medicine market is growing at 31% CAGR, outpacing the global average of 30.7%, driven by increasing healthcare digitalization and investment in advanced diagnostic technologies across smaller European markets.

Significant Revenue Growth :

Market valuation is projected to surge from $41.99 million in 2024 to $212.47 million by 2029, representing a five-fold increase that reflects strong regional adoption of AI-powered personalized treatment solutions.

Genomic & ML Integration :

Rest Of Europe is leveraging advances in machine learning algorithms and genomic sequencing technologies to enhance diagnostic accuracy and enable tailored therapeutic interventions across diverse patient populations.

Healthcare Innovation Hub :

Emerging European markets are establishing themselves as innovation centers for precision medicine, with growing collaborations between healthcare providers, biotech firms, and AI solution developers driving market penetration.

Rest Of Europe AI in Precision Medicine Market Dynamics

  • The region's smaller healthcare systems are rapidly adopting AI technologies to improve diagnostic efficiency and patient outcomes while managing costs effectively. Key growth catalysts include expanding genomic databases, improved reimbursement policies for AI-driven diagnostics, and strengthening partnerships between regional healthcare institutions and technology providers.
  • As Rest Of Europe continues to modernize its healthcare infrastructure, AI-powered precision medicine solutions will become increasingly integral to clinical decision-making and treatment planning across the region..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Analytical And Scientific Instrumentation

    Top Technologies
    • Environmental Testing
    • Gas Chromatography
    • Polymerase Chain Reaction (PCR)
    • Automated Liquid Handling Systems
    • Flow Cytometry
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Shimadzu Corporation
    • Merck KGaA

      Healthcare Analytics

      Top Technologies
      • Machine Learning
      • Natural Language Processing (NLP)
      • Blood Pressure Monitors
      • Computed Tomography (CT)
      • Magnetic Resonance Imaging (MRI)
      Top Companies
      • Oracle Corporation
      • PHILIPS HEALTHCARE
      • Siemens healthineers
      • Zensar Technologies Limited
      • EPIC SYSTEMS CORPORATION

        Key Takeaways

        • Rest Of Europe's AI in Precision Medicine market will grow from $41.99M (2024) to $212.47M (2029) at a 31.0% CAGR.
        • Rest Of Europe is accelerating AI adoption in genomics, oncology, and cardiology to improve diagnostic accuracy and treatment personalization.
        • Rest Of Europe's healthcare systems are prioritizing digital transformation and AI infrastructure investment to enhance clinical outcomes.
        • Rest Of Europe is emerging as a competitive precision medicine hub through cross-border research collaboration and regulatory harmonization.

        AI in Precision Medicine Market Report Scope

        Report Metric Details
        Base Year 2024
        Fastest Growing Segment IMAGE ANALYSIS (Tool)
        Forecast Period 2024-2029
        Growth Rate CAGR of 30.7% from 2024 to 2029
        Largest Segment SOFTWARE (Component)
        Market Size Base Year (Billions) ~USD 0.79 (2024)
        Revenue Forecast (Billions) ~USD 3.92 (2029)
        Segments Covered Application, Type, Therapeutic Area, Component, Tool, Deployment, End User, Deployment 2022-2030

        Rest Of Europe AI in Precision Medicine Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Application

        • Clinical Development
        • De Novo Drug Design
        • Diagnostic & Screening
        • Diagnostics & Screening
        • Drug Discovery
        • Drug Discovery & Development
        • Drug Optimization
        • Drug Repurposing
        • Safety
        • Therapeutics
        • Understanding Diseases

        By Type

        • Deep Learning
        • Disease Diagnosis
        • Disease Progression, Staging & Prognosis
        • Disease Screening
        • Other Machine Learning Types
        • Post Treatment Surveillance & Follow-Up
        • Reinforcement Learning
        • Risk Assessment & Patient Stratification
        • Supervised Learning
        • Therapy Monitoring
        • Therapy Selection & Planning
        • Unsupervised Learning

        By Therapeutic Area

        • Cardiology
        • Hematology
        • Infectious Diseases
        • Neurology
        • Oncology
        • Other Therapeutic Area
        • Other Therapeutic Areas
        • Rare Disease
        • Rare Diseases

        By Component

        • Services
        • Software

        By Tool

        • Computer Vision
        • Context Aware Processing
        • Context-Aware Processing
        • Context-Aware Processing & Computing
        • Image Analysis
        • Machine Learning
        • Natural Language Processing
        • Nlp
        • Other Tools

        By Deployment

        • Cloud-Based
        • Cloud-Based Model
        • Hybrid
        • Hybrid Model
        • On-Premise
        • On-Premise Model

        By End User

        • Healthcare Providers
        • Medical Device/Equipment Companies
        • Other End Users
        • Pharmaceutical & Biotechnology Companies
        • Research Centers, Academic Institutes & Government Organizations
        • Research Centers, Academic Institutes, & Government Organizations

        By Deployment 2022-2030

        • Cloud Based
        • Cloud-Based
        • Hybrid
        • On-Premise

        Target Audience

        • Healthcare Technology Vendors : AI and precision medicine solution providers need Rest Of Europe-specific market data to identify expansion opportunities, tailor product offerings to regional healthcare needs, and develop localized go-to-market strategies.
        • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities require detailed Rest Of Europe market analysis to assess growth potential, competitive positioning, and return on investment in emerging European precision medicine markets.
        • Healthcare Providers & Hospital Networks : Regional healthcare institutions need market insights to benchmark AI adoption rates, evaluate technology partnerships, and make informed procurement decisions aligned with Rest Of Europe's clinical and financial priorities.
        • Pharmaceutical & Biotech Companies : Drug developers and biotech firms require Rest Of Europe market intelligence to identify precision medicine opportunities, understand patient stratification trends, and develop region-specific clinical trial and commercialization strategies.
        • Government & Healthcare Policy Makers : Regional health authorities and policymakers need market data to inform digital health initiatives, reimbursement policies, and healthcare infrastructure investments supporting AI-driven precision medicine adoption across Rest Of Europe.

        Reasons to Buy this Report

        • Regional Market Sizing & Forecasts : Obtain precise valuation data specific to Rest Of Europe ($41.99M in 2024, $212.47M by 2029) with detailed year-by-year projections to support strategic planning and investment decisions in this high-growth regional market.
        • Competitive Landscape Analysis : Understand the competitive dynamics, key players, and market positioning strategies unique to Rest Of Europe's AI precision medicine ecosystem, enabling informed competitive benchmarking and partnership identification.
        • Growth Driver Identification : Identify region-specific growth catalysts including regulatory frameworks, healthcare infrastructure investments, and adoption barriers particular to Rest Of Europe that influence market expansion and opportunity timing.
        • Investment & Expansion Strategy : Leverage Rest Of Europe-focused insights to develop targeted market entry strategies, assess investment viability, and prioritize geographic expansion within smaller European markets with high growth potential.
        • Stakeholder Decision Support : Equip healthcare providers, technology vendors, and investors with actionable Rest Of Europe market intelligence to guide product development, partnership strategies, and resource allocation decisions.

        Frequently asked questions

        What is the market size of AI in Precision Medicine in Rest Of Europe?

        Rest Of Europe's AI in Precision Medicine market was valued at $41.99 million in 2024 and is forecast to reach $212.47 million by 2029.

        What is the CAGR for AI in Precision Medicine in Rest Of Europe?

        Rest Of Europe's AI in Precision Medicine market is projected to grow at a compound annual growth rate of 31.0% from 2024 to 2029.

        What are the primary drivers of growth in Rest Of Europe's precision medicine market?

        Rest Of Europe's market growth is driven by healthcare digitalization, increasing chronic disease prevalence, regulatory support, and investment in AI infrastructure and talent development.

        Which therapeutic areas are leading AI adoption in Rest Of Europe?

        Rest Of Europe is seeing significant AI adoption in genomics, oncology, and cardiology, where machine learning enhances diagnostic accuracy and treatment personalization.

        How is Rest Of Europe positioning itself competitively in precision medicine?

        Rest Of Europe is strengthening its position through cross-border research collaboration, public-private partnerships, regulatory harmonization, and strategic investment in AI talent and infrastructure.

        RESEARCH METHODOLOGY

        The study involved significant activities to estimate the current size of the AI in precision medicine market. Exhaustive secondary research was done to collect information on the AI in precision medicine market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in precision medicine market.

        Secondary Research

        This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in precision medicine solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

        Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in precision medicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in precision medicine market.

        After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in precision medicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

        In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Breakdown of Primary Participants:

        AI in Precision Medicine Market

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in precision medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

        • The key players in the industry and markets have been identified through extensive secondary research.
        • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
        • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
        AI in Precision Medicine Market

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        The AI in precision medicine market utilises AI technologies such as machine learning and natural language processing to analyse complicated biological and clinical data in order to provide possibly personalised healthcare solutions. It promotes applications such as drug discovery, diagnostics, predictive analytics, and tailored treatment plans by integrating genomics, proteomics, and real-world data using AI capabilities with the goal of improving patient outcomes and accelerating innovation benefits for stakeholders ranging from pharmaceutical companies and healthcare providers to researchers.

        Stakeholders

        • Transfection products manufacturing companies
        • Pharmaceutical & Biopharmaceutical Companies
        • Chemical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Contract Development and Manufacturing Organizations (CDMOs)
        • Research Institutes and Universities 
        • Venture Capitalists & Investors
        • Government Associations

        Report Objectives

        • To define, describe, and forecast the AI in precision medicine market based on application, therapeutic area, component, tools, deployment, end user, and region.
        • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
        • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
        • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
        • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
        • To profile the key players and comprehensively analyze their market sizes and core competencies.
        • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally.

        Get the Full AI in Precision Medicine Market Report

        Full forecast, segment splits, and company analysis for all AI in Precision Medicine Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status